Comparison of efficacy of Tc-99m HIG and Tc-99m nanocolloid on sentinel lymph node mapping in patients with breast cancer

Nuclear Medicine Communications

Volumn 31, Issue 10, 2010, Pages 903-909

  Yalçin, Hulya ^a   Gençoglu, Esra Arzu ^b   Yagmurdur, Mahmut ^b   Aras, Murat ^b   Ozen, Aynur ^b   Aktas, Ayse ^b  

^a MUSTAFA KEMAL UNIVERSITY   (Turkey)

^b BASKENT UNIVERSITY   (Turkey)

Author keywords

early stage breast cancer; intraoperative c probe; lymphoscintigraphy; Tc 99m HIG; Tc 99m nanocolloid

Indexed keywords

BLUE DYE; DYE; HUMAN POLYCLONAL IMMUNOGLOBULIN TC 99M; NANOCOLLOID TC 99M; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER GRADING; CANCER LOCALIZATION; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; INTRAOPERATIVE GAMMA PROBE; ISOTOPE LABELING; LYMPHOSCINTIGRAPHY; METASTASIS; SENTINEL LYMPH NODE;

BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOGLOBULINS; INTRAOPERATIVE PERIOD; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; RADIONUCLIDE IMAGING; RETROSPECTIVE STUDIES; SCINTILLATION COUNTING; SENTINEL LYMPH NODE BIOPSY; TECHNETIUM; TECHNETIUM TC 99M AGGREGATED ALBUMIN;

EID: 77957348872     PISSN: 01433636     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNM.0b013e32833dedbf     Document Type: Article

References (45)

1. Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24740 breast cancer cases. Cancer 1989; 63:181-187.
2. Ververs JM, Roumen RM, Vingerhoets AJ, Vreugdenhil G, Coebergh JW, Crommelin MA, et al. Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer. Eur J Cancer 2001; 37:991-999.
3. Trifiro G, Viale G, Gentilini O, Travaini LL, Paganelli G. Sentinel node detection in pre-operative axillary staging. Eur J Nucl Med 2004; 31:46-55.
4. Allweis TM, Badriyyah M, Bar Ad V, Cohen T, Freund HR. Current controversies in sentinel lymph node biopsy for breast cancer. Breast 2003; 12:163-171.
5. Borgstein PJ, Pijpers R, Comans EF, van Diest PJ, Boom RP, Meijer S. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 1998; 186:275-283.
6. Maffioli L, Sturm E, Roselli M, Fontanelli R, Pauwels E, Bombardieri E. State of the art of sentinel node biopsy in oncology. Tumori 2000; 86:263-272.
7. Tuttle TM. Technical advances in sentinel lymph node biopsy for breast cancer. Am Surg 2004; 70:407-413.
8. Alazraki NP, Styblo T, Grant SF, Cohen C, Larsen T, Aarsvold JN. Sentinel node staging of early breast cancer using lymphoscintigraphy and the intraoperative gamma-detecting probe. Semin Nucl Med 2000; 30:56-64.
9. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993; 2:335-340.
10. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994; 220:391-401.
11. Albertini JJ, Lyman GH, Cox C, Yeatman T, Balducci L, Ku N, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996; 276:1818-1822.
12. Uren RF, Howman-Giles RB, Thompson JF, Malouf D, Ramsey-Stewart G, Niesche FW, et al. Mammary lymphoscintigraphy in breast cancer. J Nucl Med 1995; 36:1775-1780.
13. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997; 349:1864-1867.
14. Eshima D, Fauconnier T, Eshima L, Thornback JR. Radiopharmaceuticals for lymphoscintigraphy: including dosimetry and radiation considerations. Semin Nucl Med 2000; 30:25-32.
15. 99mTc M I B I '. Ann Nucl Med 2002; 16:121-126.
16. Sainte-Marie G, Peng FS, Belisle C. Overall architecture and pattern of Iymph flow in the rat Iymph node. Am J Anat 1982; 164:275-309.
17. Uren RF, Thompson JF, Howman-Giles RB. Sentinel Iymph node biopsy in breast cancer. Lancet 1998; 352:1471-1473.
18. Swartz MA, Berk DA, Jain RK. Transport in Iymphatic capillaries: macroscopic measurements using residence time distribution theory. Am J Physiol 1996; 270:324-329.
19. O'Hea BJ, Hill AD, El-Shirbiny AM, Yeh SD, Rosen PP, Coit DG, et al. Sentinel Iymph node biopsy in breast cancer. Initial experience at Memorial Sloan-Kettering Cancer Center. J am Coll Surg 1998; 186:423-427.
20. Ergun EL, Bozkurt MF, Ercan MT, Ruacan S, Sener B, Unsal IS. Detection of inflammatory lymph nodes in rabbits by Tc-99m-HIG lymphoscintigraphy. Nucl Med Commun 2002; 23:1177-1182.
21. Svensson W, Glass DM, Bradley D, Peters AM. Measurement of lymphatic function with technetium-99m-labelled polyclonal immunoglobulin. Eur J Nucl Med 1999; 26:504-510.
22. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977; 39:456-466.
23. Kapteijn BA, Nieweg OE, Petersen JL, Rutgers EJ, Hart AA, van Dongen JA, et al. Identification and biopsy of the sentinel lymph node in breast cancer. Eur J Surg Oncol 1998; 24:427-430.
24. Ilum L, Bak M, Olsen KE, Kryh D, Berg V, Axelsson CK. Sentinel node localization in breast cancer patients using intradermal dye injection. Acta Oncol 2000; 39:423-428.
25. Bergqvist L, Strand SE, Persson BR. Particle sizing and biokinetics of interstitial lymphoscintigraphic agents. Semin Nucl Med 1983; 13:9-19.
26. Glass E, Essner R, Guiliano E. Sentinel node lokalization in breast cancer. Semin Nucl Med 1999; 29:57-68. (Pubitemid 29061431)
27. Nathanson SD, Anaya P, Karvelis KC, Eck L, Havstad S. Sentinel lymph node uptake of two different technetium-labeled radiocolloids. Ann Surg Onc 1997; 4:104-110.
28. Strand S-E, Persson BRR. Quantitative lymphoscintigraphy I: basic concept for optimal uptake of radiocolloids in the parasternal lymph nodes of rabbits. J Nucl Med 1979; 20:1038-1046.
29. Bostick PJ, Guilino EA. Vital dyesin sentinal node localization. Semin in Nucl Med 2000; 30:18-24.
30. Pain SJ, Nicholas RS, Barber RW, Ballinger JR, Purushotham AD, Mortimer PS, et al. Quantification of lymphatic function for investigation of lymphedema: depot clearance and rate of appearance of soluble macromolecules in blood. J Nucl Med 2002; 43:318-324.
31. Chu KU, Giuliano AE. Potential and pitfalls of sentinel node detection in breast cancer. Recent Results In. Cancer Res 2000; 157:237-249.
32. Morita ET, Chang J, Leong SP. Principles and controversies in lymphoscintigraphy with emphasis on breast cancer. Surg Clin North Am 2000; 80:1721-1739.
33. 99mTc-labelled radiopharmaceuticals for sentinel lymph node identification. Nucl Med Commun 2001; 22:499-504.
34. 99mTc-HIG for sentinel lymph node mapping in breast cancer patients. Nucl Med Commun 2005; 26:781-786.
35. Fowler JC, Solanki CK, Barber RW, Swift EA, Guenther I, Ballinger JR, et al. Measurement of the extraction fractions of nanocolloid and polyclonal immunoglobulin by axillary lymph nodes in patients with breast cancer. Nucl Med Commun 2004; 25:935-940.
36. O'Mahony S, Rose SL, Chilvers AJ, Ballinger JR, Solanki CK, Barber RW, et al. Finding an optimal method for imaging lymphatic vessels of the upper limb. Eur J Nucl Med Mol Imaging 2004; 31:555-563.
37. Pain SJ, Barber RW, Ballinger JR, Solanki CK, O'Mahony S, Mortimer PS, et al. Side-to-side symmetry of radioprotein transfer from tissue space to systemic vasculature following subcutaneous injection in normal subjects and patients with breast cancer. Eur J Nucl Med Mol Imaging 2003; 30:657-661.
38. Fowler JC, Solanki CK, Ballinger JR, Ravichandran D, Douglas-Jones A, Lawrence D, et al. Axillary lymph node drainage pathways from intradermal and intraparenchymal breast planes. J Surg Res 2009. [Epub ahead of print]
39. Fowler JC, Britton TB, Provenzano E, Ravichandran D, Lawrence D, Solanki CK, et al. Measurement of lymph node function from the extraction of immunoglobulin in lymph. Scand J Clin Lab Invest 2010; 70:112-115.
40. Sutton R, Kollias J, Prasad V, Chatterton B, Gill PG. Same-day lymphoscintigraphy and sentinel lymph node biopsy for early breast cancer. ANZ J Surg 2002; 72:542-546.
41. Offdile R, Hoh C, Barsky SH, Nelson SD, Elashoff R, Eilber FR, et al. Minimally invasive breast carcinoma staging using lymphatic mapping with radiolabelled dextran. Cancer 1998; 82:1704-1708.
42. Cox CE, Pendas S, Cox JM, Joseph E, Shons AR, Yeatman T, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 1998; 226:645-653.
43. Pijpers R, Meijer S, Hoekstra OS, Collet GJ, Comans EFI, Bo van Diest PJ, et al. Impact of lymphoscintigraphy on sentinel node identification with Tc-99m colloidal albumin in breast cancer. J Nucl Med 1997; 38:366-368.
44. Shons A, Joseph E, Cox CE. Predictions of sentinel lymph node metastasis in the lymphatic mapping of breast cancer patients. Breast Cancer Res Treat 1997; 46:24.
45. Crossin JA, Johnson AC, Stewart PB, Turner WW Jr. Gamma probe-guided resection of the sentinel lymph node in breast cancer. Am Surg 1998; 64:666-668.